Promiscuous evolution of Group A Streptococcal M and M-like proteins. 2023

Hannah R Frost, and Julien Guglielmini, and Sebastian Duchêne, and Jake A Lacey, and Martina Sanderson-Smith, and Andrew C Steer, and Mark J Walker, and Anne Botteaux, and Mark R Davies, and Pierre R Smeesters
Molecular Bacteriology Laboratory, Université libre de Bruxelles, Brussels, Belgium.

Group A Streptococcus (GAS) M and M-like proteins are essential virulence factors and represent the primary epidemiological marker of this pathogen. Protein sequences encoding 1054 M, Mrp and Enn proteins, from 1668 GAS genomes, were analysed by SplitsTree4, partitioning around medoids and co-occurrence. The splits network and groups-based analysis of all M and M-like proteins revealed four large protein groupings, with multiple evolutionary histories as represented by multiple edges for most splits, leading to 'M-family-groups' (FG) of protein sequences: FG I, Mrp; FG II, M protein and Protein H; FG III, Enn; and FG IV, M protein. M and Enn proteins formed two groups with nine sub-groups and Mrp proteins formed four groups with ten sub-groups. Discrete co-occurrence of M and M-like proteins were identified suggesting that while dynamic, evolution may be constrained by a combination of functional and virulence attributes. At a granular level, four distinct family-groups of M, Enn and Mrp proteins are observable, with Mrp representing the most genetically distinct of the family-group of proteins. While M and Enn protein families generally group into three distinct family-groups, horizontal and vertical gene flow between distinct GAS strains is ongoing.

UI MeSH Term Description Entries
D002352 Carrier Proteins Proteins that bind or transport specific substances in the blood, within the cell, or across cell membranes. Binding Proteins,Carrier Protein,Transport Protein,Transport Proteins,Binding Protein,Protein, Carrier,Proteins, Carrier
D000942 Antigens, Bacterial Substances elaborated by bacteria that have antigenic activity. Bacterial Antigen,Bacterial Antigens,Antigen, Bacterial
D001425 Bacterial Outer Membrane Proteins Proteins isolated from the outer membrane of Gram-negative bacteria. OMP Proteins,Outer Membrane Proteins, Bacterial,Outer Membrane Lipoproteins, Bacterial
D001426 Bacterial Proteins Proteins found in any species of bacterium. Bacterial Gene Products,Bacterial Gene Proteins,Gene Products, Bacterial,Bacterial Gene Product,Bacterial Gene Protein,Bacterial Protein,Gene Product, Bacterial,Gene Protein, Bacterial,Gene Proteins, Bacterial,Protein, Bacterial,Proteins, Bacterial
D013297 Streptococcus pyogenes A species of gram-positive, coccoid bacteria isolated from skin lesions, blood, inflammatory exudates, and the upper respiratory tract of humans. It is a group A hemolytic Streptococcus that can cause SCARLET FEVER and RHEUMATIC FEVER. Flesh-Eating Bacteria,Streptococcus Group A,Bacteria, Flesh-Eating
D037521 Virulence Factors Those components of an organism that determine its capacity to cause disease but are not required for its viability per se. Two classes have been characterized: TOXINS, BIOLOGICAL and surface adhesion molecules that effect the ability of the microorganism to invade and colonize a host. (From Davis et al., Microbiology, 4th ed. p486) Pathogenicity Factor,Pathogenicity Factors,Virulence Factor,Factor, Pathogenicity,Factor, Virulence,Factors, Pathogenicity,Factors, Virulence

Related Publications

Hannah R Frost, and Julien Guglielmini, and Sebastian Duchêne, and Jake A Lacey, and Martina Sanderson-Smith, and Andrew C Steer, and Mark J Walker, and Anne Botteaux, and Mark R Davies, and Pierre R Smeesters
March 2018, FEMS microbiology reviews,
Hannah R Frost, and Julien Guglielmini, and Sebastian Duchêne, and Jake A Lacey, and Martina Sanderson-Smith, and Andrew C Steer, and Mark J Walker, and Anne Botteaux, and Mark R Davies, and Pierre R Smeesters
June 1972, Infection and immunity,
Hannah R Frost, and Julien Guglielmini, and Sebastian Duchêne, and Jake A Lacey, and Martina Sanderson-Smith, and Andrew C Steer, and Mark J Walker, and Anne Botteaux, and Mark R Davies, and Pierre R Smeesters
March 2015, Clinical and vaccine immunology : CVI,
Hannah R Frost, and Julien Guglielmini, and Sebastian Duchêne, and Jake A Lacey, and Martina Sanderson-Smith, and Andrew C Steer, and Mark J Walker, and Anne Botteaux, and Mark R Davies, and Pierre R Smeesters
September 1992, Immunology today,
Hannah R Frost, and Julien Guglielmini, and Sebastian Duchêne, and Jake A Lacey, and Martina Sanderson-Smith, and Andrew C Steer, and Mark J Walker, and Anne Botteaux, and Mark R Davies, and Pierre R Smeesters
January 1997, Advances in experimental medicine and biology,
Hannah R Frost, and Julien Guglielmini, and Sebastian Duchêne, and Jake A Lacey, and Martina Sanderson-Smith, and Andrew C Steer, and Mark J Walker, and Anne Botteaux, and Mark R Davies, and Pierre R Smeesters
April 1989, Journal of immunology (Baltimore, Md. : 1950),
Hannah R Frost, and Julien Guglielmini, and Sebastian Duchêne, and Jake A Lacey, and Martina Sanderson-Smith, and Andrew C Steer, and Mark J Walker, and Anne Botteaux, and Mark R Davies, and Pierre R Smeesters
August 1976, Canadian journal of microbiology,
Hannah R Frost, and Julien Guglielmini, and Sebastian Duchêne, and Jake A Lacey, and Martina Sanderson-Smith, and Andrew C Steer, and Mark J Walker, and Anne Botteaux, and Mark R Davies, and Pierre R Smeesters
January 1995, Autoimmunity,
Hannah R Frost, and Julien Guglielmini, and Sebastian Duchêne, and Jake A Lacey, and Martina Sanderson-Smith, and Andrew C Steer, and Mark J Walker, and Anne Botteaux, and Mark R Davies, and Pierre R Smeesters
December 1987, The Journal of experimental medicine,
Hannah R Frost, and Julien Guglielmini, and Sebastian Duchêne, and Jake A Lacey, and Martina Sanderson-Smith, and Andrew C Steer, and Mark J Walker, and Anne Botteaux, and Mark R Davies, and Pierre R Smeesters
February 2021, PLoS pathogens,
Copied contents to your clipboard!